(Q40733201)

23 September 2017

title

Receptor profile of P88-8991 and P95-12113, metabolites of the novel antipsychotic iloperidone (English)

1 reference

23 September 2017

author name string

Natarajan Subramanian

series ordinal

1

1 reference

23 September 2017

Hans O Kalkman

series ordinal

2

1 reference

23 September 2017

publication date

1 April 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

23 September 2017

published in

1 reference

23 September 2017

volume

26

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

553-560

1 reference

Alpha2C-adrenoceptor-overexpressing mice are impaired in executing nonspatial and spatial escape strategies.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Molecular approaches to receptors as targets for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Iloperidone binding to human and rat dopamine and 5-HT receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Schizophrenia, the dopamine hypothesis and alpha2-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Refractory schizophrenia and atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

The dopamine hypothesis of schizophrenia: current status, future prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900307-4

7 January 2021

10.1016/S0278-5846(01)00307-4

Identifiers

DOI

1 reference

23 September 2017

1 reference